nodes	percent_of_prediction	percent_of_DWPC	metapath
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—E2F1—ocular cancer	0.00432	0.00432	CbGpPWpGaD
Clenbuterol—TNF—Transcriptional regulation of white adipocyte differentiation—CDK4—ocular cancer	0.00425	0.00425	CbGpPWpGaD
Clenbuterol—TNF—Aryl Hydrocarbon Receptor—CDKN1A—ocular cancer	0.00401	0.00401	CbGpPWpGaD
Clenbuterol—NGF—SIDS Susceptibility Pathways—EP300—ocular cancer	0.00394	0.00394	CbGpPWpGaD
Clenbuterol—NGF—NGF signalling via TRKA from the plasma membrane—MDM2—ocular cancer	0.00394	0.00394	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—CDKN1B—ocular cancer	0.00388	0.00388	CbGpPWpGaD
Clenbuterol—TNF—Aryl Hydrocarbon Receptor Pathway—EP300—ocular cancer	0.00381	0.00381	CbGpPWpGaD
Clenbuterol—TNF—Aryl Hydrocarbon Receptor—EP300—ocular cancer	0.00381	0.00381	CbGpPWpGaD
Clenbuterol—ADRB1—Calcium Regulation in the Cardiac Cell—GNA11—ocular cancer	0.00376	0.00376	CbGpPWpGaD
Clenbuterol—TNF—Angiopoietin receptor Tie2-mediated signaling—CDKN1A—ocular cancer	0.00375	0.00375	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—CDK2—ocular cancer	0.00373	0.00373	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—E2F1—ocular cancer	0.0037	0.0037	CbGpPWpGaD
Clenbuterol—ADRB2—Calcium Regulation in the Cardiac Cell—GNA11—ocular cancer	0.00368	0.00368	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—HDAC1—ocular cancer	0.0036	0.0036	CbGpPWpGaD
Clenbuterol—NGF—NGF signalling via TRKA from the plasma membrane—CDKN1B—ocular cancer	0.00359	0.00359	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—CDKN1A—ocular cancer	0.00358	0.00358	CbGpPWpGaD
Clenbuterol—ADRB1—Calcium Regulation in the Cardiac Cell—GNAQ—ocular cancer	0.00349	0.00349	CbGpPWpGaD
Clenbuterol—TNF—Adipogenesis—E2F1—ocular cancer	0.00343	0.00343	CbGpPWpGaD
Clenbuterol—ADRB2—Calcium Regulation in the Cardiac Cell—GNAQ—ocular cancer	0.00342	0.00342	CbGpPWpGaD
Clenbuterol—NGF—PI3K/AKT activation—AKT1—ocular cancer	0.00337	0.00337	CbGpPWpGaD
Clenbuterol—TNF—TGF-beta Receptor Signaling—EP300—ocular cancer	0.00335	0.00335	CbGpPWpGaD
Clenbuterol—TNF—Aryl Hydrocarbon Receptor—MYC—ocular cancer	0.00332	0.00332	CbGpPWpGaD
Clenbuterol—NGF—NGF signalling via TRKA from the plasma membrane—CDKN1A—ocular cancer	0.00332	0.00332	CbGpPWpGaD
Clenbuterol—TNF—Aryl Hydrocarbon Receptor Pathway—TGFB1—ocular cancer	0.00331	0.00331	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—SAG—ocular cancer	0.00329	0.00329	CbGpPWpGaD
Clenbuterol—NGF—MAPK Signaling Pathway—MYC—ocular cancer	0.00324	0.00324	CbGpPWpGaD
Clenbuterol—NGF—MAPK Signaling Pathway—TGFB1—ocular cancer	0.00323	0.00323	CbGpPWpGaD
Clenbuterol—TNF—Ceramide signaling pathway—MYC—ocular cancer	0.00321	0.00321	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—CDK2—ocular cancer	0.00319	0.00319	CbGpPWpGaD
Clenbuterol—TNF—Amyotrophic lateral sclerosis (ALS)—TP53—ocular cancer	0.00318	0.00318	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—RB1—ocular cancer	0.00306	0.00306	CbGpPWpGaD
Clenbuterol—NGF—Signaling by NGF—MDM2—ocular cancer	0.00303	0.00303	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—CDK4—ocular cancer	0.00302	0.00302	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis—E2F1—ocular cancer	0.00298	0.00298	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis—MDM2—ocular cancer	0.00294	0.00294	CbGpPWpGaD
Clenbuterol—TNF—TGF-beta Receptor Signaling—TGFB1—ocular cancer	0.00292	0.00292	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—E2F5—ocular cancer	0.00291	0.00291	CbGpPWpGaD
Clenbuterol—NGF—BDNF signaling pathway—HRAS—ocular cancer	0.00288	0.00288	CbGpPWpGaD
Clenbuterol—TNF—Cardiac Hypertrophic Response—TGFB1—ocular cancer	0.00287	0.00287	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—E2F4—ocular cancer	0.00285	0.00285	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—RBL1—ocular cancer	0.00279	0.00279	CbGpPWpGaD
Clenbuterol—NGF—Signaling by NGF—CDKN1B—ocular cancer	0.00276	0.00276	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—E2F1—ocular cancer	0.00275	0.00275	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.00275	0.00275	CbGpPWpGaD
Clenbuterol—TNF—Signaling events mediated by HDAC Class I—EP300—ocular cancer	0.00273	0.00273	CbGpPWpGaD
Clenbuterol—NGF—MAPK Signaling Pathway—TP53—ocular cancer	0.00266	0.00266	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—RB1—ocular cancer	0.00263	0.00263	CbGpPWpGaD
Clenbuterol—CYP1A1—Tryptophan metabolism—MDM2—ocular cancer	0.00261	0.00261	CbGpPWpGaD
Clenbuterol—TNF—Aryl Hydrocarbon Receptor—HRAS—ocular cancer	0.00261	0.00261	CbGpPWpGaD
Clenbuterol—NGF—Signaling by NGF—CDKN1A—ocular cancer	0.00255	0.00255	CbGpPWpGaD
Clenbuterol—NGF—BDNF signaling pathway—AKT1—ocular cancer	0.00254	0.00254	CbGpPWpGaD
Clenbuterol—TNF—Transcriptional regulation of white adipocyte differentiation—EP300—ocular cancer	0.00253	0.00253	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.00252	0.00252	CbGpPWpGaD
Clenbuterol—TNF—TWEAK Signaling Pathway—AKT1—ocular cancer	0.00248	0.00248	CbGpPWpGaD
Clenbuterol—TNF—Adipogenesis—RB1—ocular cancer	0.00243	0.00243	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—E2F3—ocular cancer	0.00242	0.00242	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ocular cancer	0.00238	0.00238	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1B—ocular cancer	0.00238	0.00238	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—CDK2—ocular cancer	0.00238	0.00238	CbGpPWpGaD
Clenbuterol—TNF—TGF-beta Receptor Signaling—HRAS—ocular cancer	0.0023	0.0023	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—TFDP1—ocular cancer	0.00225	0.00225	CbGpPWpGaD
Clenbuterol—NGF—MAPK Signaling Pathway—AKT1—ocular cancer	0.00225	0.00225	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—CCND3—ocular cancer	0.00223	0.00223	CbGpPWpGaD
Clenbuterol—TNF—Ceramide signaling pathway—AKT1—ocular cancer	0.00223	0.00223	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1A—ocular cancer	0.0022	0.0022	CbGpPWpGaD
Clenbuterol—TNF—Transcriptional regulation of white adipocyte differentiation—TGFB1—ocular cancer	0.0022	0.0022	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.00217	0.00217	CbGpPWpGaD
Clenbuterol—NGF—NGF signalling via TRKA from the plasma membrane—HRAS—ocular cancer	0.00216	0.00216	CbGpPWpGaD
Clenbuterol—TNF—Angiopoietin receptor Tie2-mediated signaling—AKT1—ocular cancer	0.00216	0.00216	CbGpPWpGaD
Clenbuterol—TNF—Allograft Rejection—TGFB1—ocular cancer	0.00215	0.00215	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—ocular cancer	0.00209	0.00209	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—EP300—ocular cancer	0.00209	0.00209	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—AKT1—ocular cancer	0.00206	0.00206	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.00205	0.00205	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis—MYC—ocular cancer	0.00205	0.00205	CbGpPWpGaD
Clenbuterol—TNF—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—ocular cancer	0.00205	0.00205	CbGpPWpGaD
Clenbuterol—TNF—Folate Metabolism—TP53—ocular cancer	0.00204	0.00204	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—CDKN1B—ocular cancer	0.00204	0.00204	CbGpPWpGaD
Clenbuterol—TNF—Cardiac Hypertrophic Response—AKT1—ocular cancer	0.002	0.002	CbGpPWpGaD
Clenbuterol—TNF—Downstream signaling in naïve CD8+ T cells—HRAS—ocular cancer	0.00196	0.00196	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—RB1—ocular cancer	0.00195	0.00195	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—CCND1—ocular cancer	0.00195	0.00195	CbGpPWpGaD
Clenbuterol—TNF—Caspase Cascade in Apoptosis—AKT1—ocular cancer	0.00194	0.00194	CbGpPWpGaD
Clenbuterol—NGF—NGF signalling via TRKA from the plasma membrane—AKT1—ocular cancer	0.00191	0.00191	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—MYC—ocular cancer	0.00182	0.00182	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—ocular cancer	0.00182	0.00182	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—MAML2—ocular cancer	0.00179	0.00179	CbGpPWpGaD
Clenbuterol—TNF—Alzheimers Disease—TP53—ocular cancer	0.00177	0.00177	CbGpPWpGaD
Clenbuterol—TNF—Adipogenesis—CDKN1A—ocular cancer	0.00175	0.00175	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—SAG—ocular cancer	0.0017	0.0017	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis—TP53—ocular cancer	0.00169	0.00169	CbGpPWpGaD
Clenbuterol—CYP1A2—Tryptophan metabolism—MDM2—ocular cancer	0.00166	0.00166	CbGpPWpGaD
Clenbuterol—NGF—Signaling by NGF—HRAS—ocular cancer	0.00166	0.00166	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—MYC—ocular cancer	0.00156	0.00156	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—GNA11—ocular cancer	0.00156	0.00156	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—TGFB1—ocular cancer	0.00156	0.00156	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.00152	0.00152	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ocular cancer	0.00152	0.00152	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—ocular cancer	0.00152	0.00152	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—GNA11—ocular cancer	0.00151	0.00151	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—E2F5—ocular cancer	0.0015	0.0015	CbGpPWpGaD
Clenbuterol—TNF—TNF alpha Signaling Pathway—HRAS—ocular cancer	0.0015	0.0015	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—E2F4—ocular cancer	0.00147	0.00147	CbGpPWpGaD
Clenbuterol—NGF—Signaling by NGF—AKT1—ocular cancer	0.00147	0.00147	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—GNAQ—ocular cancer	0.00145	0.00145	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—RBL1—ocular cancer	0.00145	0.00145	CbGpPWpGaD
Clenbuterol—TNF—Adipogenesis—TGFB1—ocular cancer	0.00144	0.00144	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—EP300—ocular cancer	0.00144	0.00144	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—ocular cancer	0.00143	0.00143	CbGpPWpGaD
Clenbuterol—TNF—MicroRNAs in cardiomyocyte hypertrophy—AKT1—ocular cancer	0.00142	0.00142	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis—AKT1—ocular cancer	0.00142	0.00142	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—ocular cancer	0.0014	0.0014	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—GNAQ—ocular cancer	0.0014	0.0014	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.00139	0.00139	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—GNA11—ocular cancer	0.00137	0.00137	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—ocular cancer	0.00133	0.00133	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—EP300—ocular cancer	0.00133	0.00133	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.00133	0.00133	CbGpPWpGaD
Clenbuterol—TNF—TNF alpha Signaling Pathway—AKT1—ocular cancer	0.00132	0.00132	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—HDAC1—ocular cancer	0.00131	0.00131	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—TP53—ocular cancer	0.00128	0.00128	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.00128	0.00128	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—GNAQ—ocular cancer	0.00127	0.00127	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—E2F3—ocular cancer	0.00125	0.00125	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.00122	0.00122	CbGpPWpGaD
Clenbuterol—TNF—Toll-like Receptor Signaling Pathway—AKT1—ocular cancer	0.00122	0.00122	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PSPH—ocular cancer	0.00119	0.00119	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—MYC—ocular cancer	0.00118	0.00118	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—TGFB1—ocular cancer	0.00118	0.00118	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CDKN2B—ocular cancer	0.00117	0.00117	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TFDP1—ocular cancer	0.00116	0.00116	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ocular cancer	0.00116	0.00116	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—ocular cancer	0.00116	0.00116	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—E2F1—ocular cancer	0.00108	0.00108	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.00106	0.00106	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.00106	0.00106	CbGpPWpGaD
Clenbuterol—CYP1A1—PPARA activates gene expression—EP300—ocular cancer	0.00104	0.00104	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis—TP53—ocular cancer	0.00103	0.00103	CbGpPWpGaD
Clenbuterol—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—ocular cancer	0.00102	0.00102	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—SAG—ocular cancer	0.00101	0.00101	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—SAG—ocular cancer	0.000987	0.000987	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—TP53—ocular cancer	0.000968	0.000968	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—CDK4—ocular cancer	0.00096	0.00096	CbGpPWpGaD
Clenbuterol—TNF—Regulation of toll-like receptor signaling pathway—AKT1—ocular cancer	0.000951	0.000951	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MAML2—ocular cancer	0.000925	0.000925	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ocular cancer	0.000913	0.000913	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—GNA11—ocular cancer	0.000893	0.000893	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—E2F5—ocular cancer	0.000893	0.000893	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—E2F4—ocular cancer	0.000875	0.000875	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—GNA11—ocular cancer	0.000874	0.000874	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000874	0.000874	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—E2F5—ocular cancer	0.000873	0.000873	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis—AKT1—ocular cancer	0.000872	0.000872	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—RBL1—ocular cancer	0.000858	0.000858	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—E2F4—ocular cancer	0.000856	0.000856	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—RBL1—ocular cancer	0.000839	0.000839	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—GNAQ—ocular cancer	0.000831	0.000831	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—AKT1—ocular cancer	0.000818	0.000818	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—GNAQ—ocular cancer	0.000812	0.000812	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—GNA11—ocular cancer	0.000811	0.000811	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—GNA11—ocular cancer	0.000807	0.000807	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—GNA11—ocular cancer	0.000794	0.000794	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PSPH—ocular cancer	0.000756	0.000756	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—GNAQ—ocular cancer	0.000754	0.000754	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—GNAQ—ocular cancer	0.000751	0.000751	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—E2F3—ocular cancer	0.000744	0.000744	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000738	0.000738	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—GNAQ—ocular cancer	0.000738	0.000738	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—E2F3—ocular cancer	0.000727	0.000727	CbGpPWpGaD
Clenbuterol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—ocular cancer	0.000703	0.000703	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TFDP1—ocular cancer	0.000691	0.000691	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—HDAC1—ocular cancer	0.000677	0.000677	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TFDP1—ocular cancer	0.000676	0.000676	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—MDM2—ocular cancer	0.00065	0.00065	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CDKN2B—ocular cancer	0.000607	0.000607	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CDKN1B—ocular cancer	0.000594	0.000594	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—EP300—ocular cancer	0.000571	0.000571	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CCND1—ocular cancer	0.000566	0.000566	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—E2F1—ocular cancer	0.000557	0.000557	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MAML2—ocular cancer	0.000549	0.000549	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CDKN1A—ocular cancer	0.000548	0.000548	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MAML2—ocular cancer	0.000537	0.000537	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—EP300—ocular cancer	0.000521	0.000521	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—TGFB1—ocular cancer	0.000496	0.000496	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—GNA11—ocular cancer	0.000479	0.000479	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—GNA11—ocular cancer	0.000469	0.000469	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—MYC—ocular cancer	0.000454	0.000454	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—TGFB1—ocular cancer	0.000453	0.000453	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—GNAQ—ocular cancer	0.000446	0.000446	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—GNAQ—ocular cancer	0.000436	0.000436	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—HDAC1—ocular cancer	0.000402	0.000402	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—HDAC1—ocular cancer	0.000393	0.000393	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—HRAS—ocular cancer	0.000391	0.000391	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—TP53—ocular cancer	0.000373	0.000373	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GNA11—ocular cancer	0.000373	0.000373	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CDKN2B—ocular cancer	0.00036	0.00036	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—HRAS—ocular cancer	0.000357	0.000357	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CDKN2B—ocular cancer	0.000352	0.000352	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GNAQ—ocular cancer	0.000347	0.000347	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—AKT1—ocular cancer	0.000345	0.000345	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MDM2—ocular cancer	0.000336	0.000336	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—E2F1—ocular cancer	0.00033	0.00033	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—E2F1—ocular cancer	0.000323	0.000323	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—AKT1—ocular cancer	0.000315	0.000315	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—HRAS—ocular cancer	0.000313	0.000313	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CDKN1B—ocular cancer	0.000307	0.000307	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—AKT1—ocular cancer	0.000304	0.000304	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CCND1—ocular cancer	0.000293	0.000293	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CDKN1A—ocular cancer	0.000283	0.000283	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.00028	0.00028	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—AKT1—ocular cancer	0.000276	0.000276	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—EP300—ocular cancer	0.00027	0.00027	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GNA11—ocular cancer	0.000238	0.000238	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MYC—ocular cancer	0.000235	0.000235	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TGFB1—ocular cancer	0.000234	0.000234	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GNAQ—ocular cancer	0.000221	0.000221	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MDM2—ocular cancer	0.0002	0.0002	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MDM2—ocular cancer	0.000195	0.000195	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TP53—ocular cancer	0.000193	0.000193	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—HRAS—ocular cancer	0.000185	0.000185	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—HRAS—ocular cancer	0.000185	0.000185	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CDKN1B—ocular cancer	0.000182	0.000182	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—HRAS—ocular cancer	0.000181	0.000181	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—AKT1—ocular cancer	0.00018	0.00018	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000178	0.000178	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CDKN1B—ocular cancer	0.000178	0.000178	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—AKT1—ocular cancer	0.000176	0.000176	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CCND1—ocular cancer	0.000174	0.000174	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CCND1—ocular cancer	0.00017	0.00017	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CDKN1A—ocular cancer	0.000168	0.000168	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CDKN1A—ocular cancer	0.000165	0.000165	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—AKT1—ocular cancer	0.000164	0.000164	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—AKT1—ocular cancer	0.000163	0.000163	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—AKT1—ocular cancer	0.00016	0.00016	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—EP300—ocular cancer	0.00016	0.00016	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—EP300—ocular cancer	0.000157	0.000157	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MYC—ocular cancer	0.00014	0.00014	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TGFB1—ocular cancer	0.000139	0.000139	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MYC—ocular cancer	0.000136	0.000136	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TGFB1—ocular cancer	0.000136	0.000136	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—EP300—ocular cancer	0.000125	0.000125	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TP53—ocular cancer	0.000115	0.000115	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TP53—ocular cancer	0.000112	0.000112	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—HRAS—ocular cancer	0.00011	0.00011	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—HRAS—ocular cancer	0.000107	0.000107	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—AKT1—ocular cancer	9.68e-05	9.68e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—AKT1—ocular cancer	9.46e-05	9.46e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—EP300—ocular cancer	7.95e-05	7.95e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—AKT1—ocular cancer	7.53e-05	7.53e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—AKT1—ocular cancer	4.8e-05	4.8e-05	CbGpPWpGaD
